Chartwell Investment Partners, LLC Vericel Corp Transaction History

Chartwell Investment Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 30, 2020	SELL	$7.25 - $19.22 $309,270 - $819,886	-42,658 Closed	0 $0
Q4 2019 Jan 29, 2020	SELL	$13.77 - $19.2 $575,985 - $803,116	-41,829 Reduced 49.51%	42,658 $742,000
Q2 2019 Aug 19, 2019	BUY	$15.01 - $18.89 $703,578 - $885,449	46,874 Added 124.62%	84,487 $1.6 Million
Q1 2019 Apr 11, 2019	BUY	$16.23 - $20.29 $8,309 - $10,388	512 Added 1.38%	37,613 $659,000
Q4 2018 Feb 01, 2019	SELL	$10.77 - $18.44 $610,874 - $1.05 Million	-56,720 Reduced 60.46%	37,101 $646,000
Q3 2018 Nov 08, 2018	BUY	$9.1 - $14.8 $1,938 - $3,152	213 Added 0.23%	93,821 $1.33 Million
Q2 2018 Aug 09, 2018	BUY	$9.6 - $14.6 $898,636 - $1.37 Million	93,608 New	93,608 $908,000

277

48.8M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.73B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Chartwell Investment Partners, LLC with notifications on news.